
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed)
@rbryanbell
Cancer Institute Director. Head & Neck Surgeon. Clinical Researcher focused on #immunotherapy. Relentlessly working to #FinishCancer @Providence Tweets my own
ID: 4447438632
https://oregon.providence.org/our-services/p/providence-cancer-center/ 04-12-2015 00:56:17
3,3K Tweet
2,2K Takipçi
668 Takip Edilen

Delighted to present path response from our Neoadjuvant ImmunoRadioTherapy (NIRT-2) trial in pts w HPV- HNSCC ASCO mPR=71% pCR=29% Downstaging=67% Omission of adjuvant RT=83% Surgical de-escalation=50% Earle A. Chiles Research Institute UCSD Health Moores Cancer Center COE Joseph Califano UCSD Cancer #ASCO25 meetings.asco.org/abstracts-pres…
